BCIM
UTHR icon

British Columbia Investment Management’s United Therapeutics UTHR Stock Holding History

British Columbia Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
5,919
+281
+5% +$158K 0.02% 492
2026
Q1 		$3.34M Sell
5,638
-1,953
-26% -$973K 0.02% 464
2025
Q4 		$3.7M Buy
7,591
+1,432
+23% +$667K 0.02% 483
2025
Q3 		$2.58M Sell
6,159
-555
-8% -$187K 0.01% 527
2025
Q2 		$1.93M Sell
6,714
-1,397
-17% -$418K 0.01% 590
2025
Q1 		$2.5M Buy
8,111
+16
+0.2% +$5.48K 0.02% 574
2024
Q4 		$2.86M Buy
8,095
+1,061
+15% +$390K 0.02% 559
2024
Q3 		$2.52M Sell
7,034
-1,531
-18% -$517K 0.02% 565
2024
Q2 		$2.73M Buy
8,565
+2,955
+53% +$782K 0.02% 539
2024
Q1 		$1.29M Buy
5,610
+207
+4% +$46.7K 0.01% 672
2023
Q4 		$1.19M Buy
5,403
+1,140
+27% +$263K 0.01% 669
2023
Q3 		$963K Buy
4,263
+91
+2% +$21K 0.01% 650
2023
Q2 		$921K Buy
4,172
+115
+3% +$25.5K 0.01% 670
2023
Q1 		$909K Buy
+4,057
New +$1M 0.01% 670
2019
Q2 		– Sell
-9,749
Closed -$1.14M – 794
2019
Q1 		$1.14M Sell
9,749
-1,225
-11% -$143K 0.01% 735
2018
Q4 		$1.2M Sell
10,974
-35,784
-77% -$4.15M 0.01% 721
2018
Q3 		$5.98M Buy
46,758
+16,019
+52% +$1.98M 0.06% 355
2018
Q2 		$3.48M Buy
30,739
+11,591
+61% +$1.27M 0.03% 546
2018
Q1 		$2.15M Buy
19,148
+13,181
+221% +$1.67M 0.02% 646
2017
Q4 		$883K Buy
5,967
+2,974
+99% +$378K 0.01% 679
2017
Q3 		$351K Hold
2,993
– – ﹤0.01% 691
2017
Q2 		$388K Sell
2,993
-9,142
-75% -$1.14M ﹤0.01% 691
2017
Q1 		$1.64M Sell
12,135
-7,516
-38% -$1.14M 0.01% 636
2016
Q4 		$2.82M Sell
19,651
-6,325
-24% -$808K 0.02% 585
2016
Q3 		$3.07M Sell
25,976
-7,393
-22% -$888K 0.03% 546
2016
Q2 		$3.53M Buy
33,369
+154
+0.5% +$17.2K 0.03% 533
2016
Q1 		$3.7M Sell
33,215
-1,935
-6% -$245K 0.03% 521
2015
Q4 		$5.5M Buy
35,150
+28,359
+418% +$4.13M 0.05% 408
2015
Q3 		$891K Sell
6,791
-1,961
-22% -$315K 0.01% 644
2015
Q2 		$1.52M Buy
+8,752
New +$1.57M 0.01% 625

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

British Columbia Investment Management's UTHR Position: Q2 2026 in Review

British Columbia Investment Management increased its United Therapeutics (UTHR) stake by 5% in Q2 2026, buying an estimated $158K and bringing the position to 5,919 shares worth $3.21M. The position accounts for 0.02% of the portfolio, ranked #492.

British Columbia Investment Management first reported a position in UTHR in Q2 2015 and has held it in 30 quarters since. The position peaked at $5.98M in Q3 2018. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • British Columbia Investment Management held 5,919 shares of United Therapeutics worth $3.21M as of Q2 2026.
  • British Columbia Investment Management bought 281 United Therapeutics shares in Q2 2026, an estimated $158K.
  • United Therapeutics made up 0.02% of British Columbia Investment Management's portfolio in Q2 2026, its #492 holding.
  • British Columbia Investment Management first reported a position in United Therapeutics in Q2 2015 and has held it in 30 quarters since.
  • British Columbia Investment Management's United Therapeutics position peaked at $5.98M in Q3 2018.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.